DAOHE GLOBAL (00915) announced its mid-term performance, reporting a net loss of $448,000, a year-on-year decrease of 51.3%.

16:54 21/08/2026

Daohe Global (00915) announced its performance for the six months ending June 30, 2026, with revenue of $17.147 million, an increase of 13.27% year-on-year; a net loss of $448,000, a decrease of 51.3% year-on-year; and a basic loss per share of $0.03.

DAOHE GLOBAL (00915) released its performance report for the six months ending June 30, 2026, reporting revenue of $17.147 million, a 13.27% year-on-year increase; a net loss of $448,000, representing a 51.3% decrease compared to the same period last year; and a basic loss per share of $0.03. The announcement stated that the increase was primarily driven by the high gross margin of its cultural and entertainment business, with the overall gross margin slightly rising from approximately 37.3% to about 37.8%.

CGN POWER (01816) has completed the issuance of the third and fourth phases of the medium-term notes for 2026.

CHINARES PHARMA (03320): China Resources Double-Crane Pharmaceutical's net profit attributable to shareholders for the first half of the year was 946 million yuan, a year-on-year decrease of 3.43%.

SINO GAS HLDGS (01759) issues profit warning, expecting to turnaround from loss to profit in the first half of the year to approximately 500,000 - 700,000 yuan year-on-year.

CGN POWER (01816) has completed the issuance of the third and fourth phases of the medium-term notes for 2026.

CHINARES PHARMA (03320): China Resources Double-Crane Pharmaceutical's net profit attributable to shareholders for the first half of the year was 946 million yuan, a year-on-year decrease of 3.43%.

SINO GAS HLDGS (01759) issues profit warning, expecting to turnaround from loss to profit in the first half of the year to approximately 500,000 - 700,000 yuan year-on-year.